Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endostatin”

96 trials

Showing 20 of 96 results

Testing effectiveness (Phase 2)Looking for participantsNCT06617936
What this trial is testing

Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer.

Who this might be right for
Unresectable Non-small Cell Lung Cancer
Hua Zhang 36
Post-approval studies (Phase 4)UnknownNCT05782764
What this trial is testing

Endostar Combined With Chemotherapy and Immunotherapy in Lung Squamous Cell Carcinom

Who this might be right for
Lung Squamous Cell Carcinoma
Xuzhou Medical University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06611826
What this trial is testing

GEP Combined With Radiotherapy in Non-locally Treatable Recurrent NPC

Who this might be right for
Nasopharynx Cancer
Zhejiang Cancer Hospital 41
Large-scale testing (Phase 3)UnknownNCT01479036
What this trial is testing

Trial of Neoadjuvant Endostar, Docetaxel and Epirubicin for Patients With Breast Cancer

Who this might be right for
Breast Cancer
Xijing Hospital 800
Large-scale testing (Phase 3)UnknownNCT00576914
What this trial is testing

Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Chinese Academy of Sciences 1,108
Early research (Phase 1)UnknownNCT04413227
What this trial is testing

A Phase Ib Study With Pegylated Recombinant Human Endostatin in Advanced / Metastatic NSCLC or Other Solid Tumors

Who this might be right for
NSCLCSolid Tumor
Jiangsu Simcere Pharmaceutical Co., Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT02350517
What this trial is testing

Endostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
Yuhong Li 52
Large-scale testing (Phase 3)UnknownNCT02001168
What this trial is testing

Comparison of Postoperative Adjuvant Chemotherapy With/Without Rh-endostatin on Non-small Cell Lung Cancer in PhaseⅠB

Who this might be right for
Non-small Cell Lung Cancer
Xinjiang Medical University 392
Not applicableStudy completedNCT02159235
What this trial is testing

Heavy Metals, Angiogenesis Factors and Osteopontin in Coronary Artery Disease (CAD)

Who this might be right for
Ischemic Heart DiseaseCoronary Artery DiseaseHeavy Metal Toxicity
Medical University of Vienna 200
Early research (Phase 1)Study completedNCT00004229
What this trial is testing

Endostatin in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 30
Large-scale testing (Phase 3)UnknownNCT03588494
What this trial is testing

Endostar in Combination With Chemoradiotherapy in Patient With Advanced Non-small Cell Lung Cancer

Who this might be right for
Quality of Life
Affiliated Hospital of North Sichuan Medical College 318
Testing effectiveness (Phase 2)UnknownNCT06041724
What this trial is testing

Envafolimab Combined With Recombinant Human Endostatin and First-line Chemotherapy Treat of Advanced Mucosal Melanoma

Who this might be right for
Advanced Mucosal Melanoma
Fudan University 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06747169
What this trial is testing

Efficacy and Safety of Sintilimab Combined with Nab-PP Plus Rh-endostatin in Locally Advanced/advanced and Recurrent Metastatic Squamous Non-small Cell Lung Cancer: a Single-arm, Multicenter Clinical Study

Who this might be right for
Squamous Non-Small Cell Lung Cancer SqNSCLC
Jian-Guo Zhou, MD, PhD 32
Post-approval studies (Phase 4)UnknownNCT02804646
What this trial is testing

Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma

Who this might be right for
Adenocarcinoma of Lung
Anhui Provincial Hospital 100
Large-scale testing (Phase 3)Study completedNCT03117335
What this trial is testing

Recombinant Endostatin Combined With Vinorelbine and Cisplatin in Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Advanced Non-small Cell Lung Cancer
Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. 560
Testing effectiveness (Phase 2)UnknownNCT05243355
What this trial is testing

Envafolimab Combined With Chemotherapy and Recombinant Human Endostatin in the First-line Treatment of Sq-NSCLC

Who this might be right for
Squamous Non-small Cell Lung Cancer
Qilu Hospital of Shandong University 46
Testing effectiveness (Phase 2)UnknownNCT02375022
What this trial is testing

Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations

Who this might be right for
Lung Cancer
Zhejiang University 10
Testing effectiveness (Phase 2)UnknownNCT03917069
What this trial is testing

Nab-PCE vs PC for MM After Failure of Anti-PD-1

Who this might be right for
Advanced Melanoma
Peking University Cancer Hospital & Institute 145
Testing effectiveness (Phase 2)Looking for participantsNCT04267978
What this trial is testing

Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas

Who this might be right for
Glioblastoma, RecurrentLower Grade Glioma, Recurrent
Beijing Sanbo Brain Hospital 109
Not applicableStudy completedNCT04633746
What this trial is testing

Plasma Endostatin Predicts Outcome of Septic AKI

Who this might be right for
Acute Kidney Injury Due to Sepsis
Cairo University 40
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation